Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × copanlisib × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 6 Neoplasm Metastasis 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Multiple Myeloma 2 Lymphoma, Follicular 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Spinocerebellar Degenerations 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Malignant Solid Neoplasm 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hepatic Insufficiency 1 Gallbladder Neoplasms 1 Digestive System Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1

Interventions

Sunitinib 64 Nivolumab 41 pembrolizumab 34 Bevacizumab 32 Everolimus 31 Sorafenib 25 pazopanib 23 Axitinib 23 cabozantinib 13 aldesleukin 13 Ipilimumab 13 temsirolimus 11 Interferon alpha-2 11 Cyclophosphamide 10 avelumab 9 Interleukin-2 9 atezolizumab 8 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 lenvatinib 6 Disulfides 6 fludarabine phosphate 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 Vorinostat 4 Tyrosine Kinase Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡